col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


101 Ergebisse       Seite 1

 [1] 
Springer-Verlag: Clinical and Experimental Medicine
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2025―Mrz―12 VEGF-A in COVID-19: a systematic review and meta-analytical approach to its prognostic value Seyed Sobhan Bahreiny, Mohammad-Navid Bastani, Hossein Keyvani, Reza Mohammadpour Fard, Mojtaba Aghaei, Zahra Mansouri, et al. (+4)
2 [GO] 2024―Jul―13 Efficacy and safety of glucocorticoids in the treatment of COVID-19: a systematic review and meta-analysis of RCTs Xiangrong Ye, Ye Li, Feng Luo, Zhibin Xu, Kaidirina Kasimu, Juan Wang, et al. (+4)
3 [GO] 2024―Jun―10 COVID-19 pneumonia in lung transplant recipients: understanding risk factors and treatment outcomes in Japan Toshikazu Watanabe, Takashi Hirama, Miki Akiba, Tatsuaki Watanabe, Yui Watanabe, Hisashi Oishi, et al. (+2)
4 [GO] 2024―Jun―04 Managing and treating COVID-19 in patients with hematological malignancies: a narrative review and expert insights Heng Joo Ng, Maaz Kamal Alata, Quang The Nguyen, Phu Huynh Duc Vinh, Jing Yuan Tan, Chieh Lee Wong
5 [GO] 2024―Mai―17 Cardioprotective effects of vaccination in hospitalized patients with COVID-19 Julian Madrid, Prerana Agarwal, Katharina Müller-Peltzer, Leo Benning, Mischa Selig, Bernd Rolauffs, et al. (+12)
6 [GO] 2024―Apr―29 Risk factors for severe COVID-19 infection and the impact of COVID-19 infection on disease progression among patients with AAV Chen Wang, Zhi-Ying Li, Gui-Ping Jiang, Ming-Hui Zhao, Min Chen
7 [GO] 2024―Apr―23 Does the SARS-CoV-2 mRNA vaccine and its serum IgG levels affect fertility treatments and obstetric outcomes? An observational cohort study Netanella Danielli Miller, Nitzan Goren Gepstein, Dovev Cohen, Einat Haikin Herzberger, Hila Shalev Ram, Jordana Mashiach Friedler, et al. (+5)
8 [GO] 2024―Feb―24 Causality between COVID-19 and multiple myeloma: a two-sample Mendelian randomization study and Bayesian co-localization Shuaiyuan Wang, Na Zhao, Ting Luo, Songzi Kou, Miaomiao Sun, Kuisheng Chen
9 [GO] 2024―Feb―24 Clinical and pathological findings of IgA nephropathy following SARS-CoV-2 infection Hongfen Li, Zhao Li, Zhanfei Wu, Fanghao Wang, Yue Xing, Youxia Liu, et al. (+2)
10 [GO] 2024―Jan―27 Vaccination protects against acute respiratory distress syndrome (ARDS) in hospitalized patients with COVID-19 Julian Madrid, Prerana Agarwal, Katharina Müller-Peltzer, Marvin Askani, Leo Benning, Mischa Selig, et al. (+12)
11 [GO] 2024―Jan―20 Herpes zoster after the third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in actively treated cancer patients: a prospective study Fabrizio Nelli, Agnese Fabbri, Antonella Virtuoso, Diana Giannarelli, Eleonora Marrucci, Cristina Fiore, et al. (+10)
12 [GO] 2024―Jan―20 Humoral responses to wild type and ancient BA.1 SARS-CoV-2 variant after heterologous priming vaccination with ChAdOx1 nCoV-19 and BNT162b2 booster dose Giuseppina Sanna, Alessandra Marongiu, Davide Firinu, Cristina Piras, Vanessa Palmas, Massimiliano Galdiero, et al. (+9)
13 [GO] 2024―Jan―17 The demographic, laboratory and genetic factors associated with long Covid-19 syndrome: a case-control study Ensiye Torki, Fahimeh Hoseininasab, Marjan Moradi, Ramin Sami, Mark J. M. Sullman, Hamed Fouladseresht
14 [GO] 2023―Nov―16 Vaccine effectiveness of COVID-19 and rebound in the real world Myung-Bae Park, Boram Sim
15 [GO] 2023―Nov―05 A novel auxiliary diagnostic model for COVID-19 screening using enzymes based detection of serum biomarkers and clinical characteristics Lang Yi, Shuai Peng, Peilin Liu, Xianghui Liang, Qian Gao
16 [GO] 2023―Okt―31 Impact of influenza immunity on the mortality among older adults hospitalized with COVID-19: a retrospective cohort study Matthieu Coulongeat, Julien Marlet, Amal Aidoud, Flora Donati, Simon Jamard, Sylvie Van Der Werf, et al. (+5)
17 [GO] 2023―Okt―30 Correction to: The effect of corticosteroids, antibiotics, and anticoagulants on the development of post-COVID-19 syndrome in COVID-19 hospitalized patients 6 months after discharge: a retrospective follow up study John Davelaar, Naomi Jessurun, Gerko Schaap, Christina Bode, Harald Vonkeman
18 [GO] 2023―Okt―28 Effective Neutralizing Antibody Response Against SARS-CoV-2 Virus and Its Omicron BA.1 Variant in Fully Vaccinated Hematological Patients Danilo De Novellis, Veronica Folliero, Valentina Giudice, Luca Pezzullo, Giuseppina Sanna, Raffaele Fontana, et al. (+18)
19 [GO] 2023―Okt―14 Safety of COVID-19 mRNA vaccination and effects of SARS-CoV-2 infection in children and adults with mast cell disorders Catherine K. Zhu, Alex Nguyen, Connor Prosty, Sofianne Gabrielli, Pasquale Mulé, Elena Netchiporouk, et al. (+9)
20 [GO] 2023―Sep―21 Dipeptidyl-peptidase 3 and IL-6: potential biomarkers for diagnostics in COVID-19 and association with pulmonary infiltrates Stephan T. Staudner, Simon B. Leininger, Manuel J. Vogel, Julian Mustroph, Ute Hubauer, Christine Meindl, et al. (+10)
21 [GO] 2023―Sep―02 A prospective longitudinal cohort study on risk factors for COVID-19 vaccination failure (RisCoin): methods, procedures and characterization of the cohort Sibylle Koletzko, Thu Giang Le Thi, Ana Zhelyazkova, Andreas Osterman, Sven P. Wichert, Simone Breiteneicher, et al. (+52)
22 [GO] 2023―Sep―01 Associations of the COVID-19 burden and various comorbidities of different ethnic groups in Israel: a cross-sectional study Mahdi Tarabeih, Ori Perelmutter, Yona Kitay-Cohen, Aliza Amiel, Wasef Na’amnih
23 [GO] 2023―Aug―31 Is there a correlation between antibiotic use and the severity or post-infection conditions of COVID-19 and other viral infections? Tsz Yuen Au, Chanika Assavarittirong, Shamiram Benjamin, Oskar Wojciech Wiśniewski
24 [GO] 2023―Aug―28 Comparative analysis of CRP as a biomarker of the inflammatory response intensity among common viral infections affecting the lungs: COVID-19 versus influenza A, influenza B and respiratory syncytial virus Tal Levinson, Asaf Wasserman, Shani Shenhar-Tsarfaty, Ora Halutz, Itzhak Shapira, David Zeltser, et al. (+3)
25 [GO] 2023―Aug―24 Chronicling the 3-year evolution of the COVID-19 pandemic: analysis of disease management, characteristics of major variants, and impacts on pathogenicity Eleni Pitsillou, Yiping Yu, Raymond C. Beh, Julia J. Liang, Andrew Hung, Tom C. Karagiannis
26 [GO] 2023―Aug―16 Impact of methotrexate on humoral and cellular immune responses to SARS-CoV-2 mRNA vaccine in patients with rheumatoid arthritis Masahiro Shirata, Isao Ito, Masao Tanaka, Koichi Murata, Kosaku Murakami, Hiroyuki Ikeda, et al. (+10)
27 [GO] 2023―Aug―08 The effect of corticosteroids, antibiotics, and anticoagulants on the development of post-COVID-19 syndrome in COVID-19 hospitalized patients 6 months after discharge: a retrospective follow up study John Davelaar, Naomi Jessurun, Gerko Schaap, Christina Bode, Harald Vonkeman
28 [GO] 2023―Jul―21 Interactions and clinical implications of serological and respiratory variables 3 months after acute COVID-19 Ophir Freund, Anna Breslavsky, Sabrina Fried, Rotem Givoli-Vilensky, Shira Cohen-Rubin, Nadav Zacks, et al. (+6)
29 [GO] 2023―Jul―03 Knowledge mapping of COVID-19 and autoimmune diseases: a visual and bibliometric analysis Youao Zhang, Zixuan Jia, Xu Xia, Jieyan Wang
30 [GO] 2023―Jun―13 Persistent lymphocyte reduction and interleukin-6 levels are independently associated with death in patients with COVID-19 You Xu, Nianci Wang, Xiao Shen, Xu Liu, Han Liu, Ying Liu
31 [GO] 2023―Jun―08 Correction to: Changing patterns and clinical outcomes of hospitalized patients with COVID-19 severe pneumonia treated with remdesivir according to vaccination status: results from a real-world retrospective study Daniele Mengato, Maria Mazzitelli, Andrea Francavilla, Monica Bettio, Lolita Sasset, Nicolò Presa, et al. (+6)
32 [GO] 2023―Jun―05 Remdesivir in pregnant women with moderate to severe coronavirus disease 2019 (COVID-19): a retrospective cohort study Taraneh Arbabzadeh, Maryam Masoumi Shahrbabak, Parichehr Pooransari, Mahdi Khatuni, Masoumeh Mirzamoradi, Soraya Saleh Gargari, et al. (+4)
33 [GO] 2023―Mai―19 Variant-derived SARS-CoV-2 spike protein does not directly cause platelet activation or hypercoagulability Eriko Kusudo, Yutaka Murata, Shuji Kawamoto, Moritoki Egi
34 [GO] 2023―Mai―15 Side effects of COVID-19 vaccination and breast cancer Amnuay Kleebayoon, Viroj Wiwanitkit
35 [GO] 2023―Mai―11 90K/LGALS3BP expression is upregulated in COVID-19 but may not restrict SARS-CoV-2 infection Laure Bosquillon de Jarcy, Bengisu Akbil, Baxolele Mhlekude, Johanna Leyens, Dylan Postmus, Greta Harnisch, et al. (+23)
36 [GO] 2023―Apr―25 Interleukin-62/lymphocyte as a proposed predictive index for COVID-19 patients treated with monoclonal antibodies Salvatore Rotundo, Massimo Borelli, Vincenzo Scaglione, Rosaria Lionello, Flavia Biamonte, Vincenzo Olivadese, et al. (+32)
37 [GO] 2023―Apr―16 Unique immune and inflammatory cytokine profiles may define long COVID syndrome Lao-Tzu Allan-Blitz, Omid Akbari, Noah Kojima, Edwyn Saavedra, Prithivi Chellamuthu, Nicholas Denny, et al. (+8)
38 [GO] 2023―Apr―15 Modulation of IRAK enzymes as a therapeutic strategy against SARS-CoV-2 induced cytokine storm Ismail Sami Mahmoud, Yazun Bashir Jarrar
39 [GO] 2023―Apr―13 Genetic polymorphisms of ACE1, ACE2, IFTM3, TMPRSS2 and TNFα genes associated with susceptibility and severity of SARS-CoV-2 infection: a systematic review and meta-analysis Valentina Pecoraro, Michela Cuccorese, Tommaso Trenti
40 [GO] 2023―Apr―08 Side effects of COVID-19 vaccinations in patients treated for breast cancer Brooke C. Juhel, Cheryl L. Brunelle, Madison C. Bernstein, Louisa H. Smith, Amanda W. Jung, Hazim S. Ababneh, et al. (+5)
41 [GO] 2023―Apr―07 Five cluster classifications of long COVID and their background factors: A cross-sectional study in Japan Tomoya Tsuchida, Naohito Yoshimura, Kosuke Ishizuka, Kohta Katayama, Yoko Inoue, Masanori Hirose, et al. (+5)
42 [GO] 2023―Mrz―24 Changing patterns and clinical outcomes of hospitalized patients with COVID-19 severe pneumonia treated with remdesivir according to vaccination status: results from a real-world retrospective study Daniele Mengato, Maria Mazzitelli, Andrea Francavilla, Monica Bettio, Lolita Sasset, Nicolò Presa, et al. (+6)
43 [GO] 2023―Mrz―20 The top 100 most cited articles on COVID-19 vaccine: a bibliometric analysis Weigang Wang, Hu Wang, Tian Yao, Yandi Li, Linzhu Yi, Ying Gao, et al. (+3)
44 [GO] 2023―Mrz―03 Outcome of COVID-19 patients with haematological malignancies after the introduction of vaccination and monoclonal antibodies: results from the HM-COV 2.0 study Alessandra Oliva, Francesco Cogliati Dezza, Flavia Petrucci, Francesco Eugenio Romani, Matteo Morviducci, Flavio Marco Mirabelli, et al. (+9)
45 [GO] 2023―Feb―21 Comparison of immune response to SARS-COV-2 vaccine in COVID-recovered versus non-infected Individuals Saadiya Mushtaq, Muhammad Khalid Azam Khan, Muhammad Qaiser Alam Khan, Muhammad Ali Rathore, Bushra Parveen, Misbah Noor, et al. (+4)
46 [GO] 2023―Feb―16 Mortality of COVID-19 in patients with hematological malignancies versus solid tumors: a systematic literature review and meta-analysis Nicole Hardy, Charan Thej Reddy Vegivinti, Mansi Mehta, Jade Thurnham, Alexander Mebane, John M. Pederson, et al. (+13)
47 [GO] 2023―Feb―13 Outpatient anti-spike monoclonal antibody administration is associated with decreased morbidity and mortality among patients with cancer and COVID-19 Panos Arvanitis, Alexis Hope Lerner, Kendra Vieira, Nouf Almaghlouth, Dimitrios Farmakiotis
48 [GO] 2023―Feb―10 Correction to: Association of body mass index with COVID-19-related neurologic sequelae: a retrospective cohort study Sameer Elsayed, Ana Cabrera, Danielle Ouellette, Phil M. Jones, Rita Dhami, William Hanage
49 [GO] 2023―Feb―08 On the choice of Molnupiravir and Paxlovid as the only antivirals permitted for COVID-19 infection in Australia Alberto Boretti
50 [GO] 2023―Feb―06 Correction to: Protracted course of SARS-CoV-2 pneumonia in moderately to severely immunocompromised patients Jeongjae Lee, A Reum Kim, Sung Woon Kang, Euijin Chang, Seongman Bae, Jiwon Jung, et al. (+6)
51 [GO] 2023―Jan―06 Protracted course of SARS-CoV-2 pneumonia in moderately to severely immunocompromised patients Jeongjae Lee, A Reum Kim, Sung Woon Kang, Euijin Chang, Seongman Bae, Jiwon Jung, et al. (+6)
52 [GO] 2022―Dez―17 COVID in 2022. Clinical risk management of sars-cov-2 positive patients admitted to an internal medicine ward Anna Licata, Simona Amodeo, Luigi Mirarchi, Maurizio Soresi, Roberto Citarrella, Mario Barbagallo, Lydia Giannitrapani
53 [GO] 2022―Dez―16 Association of body mass index with COVID-19-related neurologic sequelae: a retrospective cohort study Sameer Elsayed, Ana Cabrera, Danielle Ouellette, Phil M. Jones, Rita Dhami, William Hanage
54 [GO] 2022―Dez―12 Use of remdesivir for COVID-19 in patients with hematologic cancer Alexandra Martin-Onraët, Corazón Barrientos-Flores, Diana Vilar-Compte, Carolina Pérez-Jimenez, Pamela Alatorre-Fernandez
55 [GO] 2022―Dez―05 Real-world clinical outcomes of treatment with molnupiravir for patients with mild-to-moderate coronavirus disease 2019 during the Omicron variant pandemic Yasuhito Suzuki, Yoko Shibata, Hiroyuki Minemura, Takefumi Nikaido, Yoshinori Tanino, Atsuro Fukuhara, et al. (+47)
56 [GO] 2022―Dez―02 The impact of the secondary infections in ICU patients affected by COVID-19 during three different phases of the SARS-CoV-2 pandemic Federica Murgia, Maura Fiamma, Silvia Serra, Giulia Marras, Raul Argiolas, Chiara Mattana, et al. (+18)
57 [GO] 2022―Nov―24 Predictive value of C-reactive protein for disease severity and survival in COVID-19 patients: a systematic review and meta-analysis Lihong Chi, Shuai Wang, Xiaoyu Wang, Chengwu Yang, Jianghong Luo
58 [GO] 2022―Nov―18 Acute and chronic histopathological findings in renal biopsies in COVID-19 Meint Volbeda, Daniela Jou-Valencia, Marius C. van den Heuvel, Jan G. Zijlstra, Casper F. M. Franssen, Peter H. J. van der Voort, et al. (+2)
59 [GO] 2022―Nov―16 Interleukin 18 and IL-18 BP response to Sars-CoV-2 virus infection Luca Marino, Anna Criniti, Sofia Guida, Tommaso Bucci, Laura Ballesio, Marianna Suppa, et al. (+6)
60 [GO] 2022―Nov―15 Presepsin levels and COVID-19 severity: a systematic review and meta-analysis Matteo Guarino, Benedetta Perna, Martina Maritati, Francesca Remelli, Caterina Trevisan, Michele Domenico Spampinato, et al. (+4)
61 [GO] 2022―Nov―13 Intermediate monocytes expansion and homing markers expression in COVID-19 patients associate with kidney dysfunction Chiara Dentone, Daniela Fenoglio, Alessia Parodi, Tiziana Altosole, Antonio Di Biagio, Federica Bozzano, et al. (+12)
62 [GO] 2022―Okt―31 Association of polymorphisms in long pentraxin 3 and its plasma levels with COVID-19 severity Thiala Alves Feitosa, Mirela Vanessa de Souza Sá, Vanessa Cardoso Pereira, Marton Kaique de Andrade Cavalcante, Valéria Rêgo Alves Pereira, Anderson da Costa Armstrong, Rodrigo Feliciano do Carmo
63 [GO] 2022―Okt―26 Evidence of SARS-CoV-2 reinfection: analysis of 35,000 subjects and overview of systematic reviews Valentina Pecoraro, Tommaso Pirotti, Tommaso Trenti
64 [GO] 2022―Okt―17 Pregnancy and COVID-19: high or low risk of vertical transmission Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Nisreen Khalid Aref Albezrah, Haitham Ahmed Bahaa, Maisra M. El-Bouseary, Athanasios Alexiou, et al. (+2)
65 [GO] 2022―Okt―07 The impact of cancer on the severity of disease in patients affected with COVID-19: an umbrella review and meta-meta-analysis of systematic reviews and meta-analyses involving 1,064,476 participants Mehmet Emin Arayici, Yasemin Basbinar, Hulya Ellidokuz
66 [GO] 2022―Sep―19 Coagulopathy during COVID-19 infection: a brief review Robin M. Cunningham, Kyle L. Johnson Moore, Jacen S. Moore
67 [GO] 2022―Sep―08 Induction of neutralizing antibodies in CLL patients after SARS-CoV-2 mRNA vaccination: a monocentric experience Claudia Baratè, Teresita Caruso, Fabrizio Mavilia, Paola Sammuri, Federico Pratesi, Giuseppe Motta, et al. (+3)
68 [GO] 2022―Sep―02 Comment on “immune response to SARS-CoV-2 mRNA vaccines in patients treated with either Ibrutinib or Rituximab” Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
69 [GO] 2022―Sep―01 Therapeutic-dose anticoagulation or thromboprophylaxis with low-molecular-weight heparin for moderate Covid-19: meta-analysis of randomized controlled trials Javier Ena, Victoria Valls
70 [GO] 2022―Aug―20 The relationship between lung fibrosis, the epidermal growth factor receptor, and disease outcomes in COVID-19 pneumonia: a postmortem evaluation Seyhan Us Dülger, Nazmi Mutlu, İlkay Ceylan, Erhan Özhan
71 [GO] 2022―Jul―18 Iron and iron-related proteins in COVID-19 Erin Suriawinata, Kosha J. Mehta
72 [GO] 2022―Jun―13 Significant association between HIV infection and increased risk of COVID-19 mortality: a meta-analysis based on adjusted effect estimates Xueya Han, Hongjie Hou, Jie Xu, Jiahao Ren, Shuwen Li, Ying Wang, et al. (+2)
73 [GO] 2022―Mai―25 Attitudes towards and safety of the SARS-CoV-2 inactivated vaccines in 188 patients with systemic lupus erythematosus: a post-vaccination cross-sectional survey Qi Tang, Fen Li, Jing Tian, Jin Kang, Jinshen He
74 [GO] 2022―Mai―24 Hyperviscosity syndrome in COVID-19 and related vaccines: exploring of uncertainties Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Maisra M. El-Bouseary, Fatma I. Sonbol, Gaber El-Saber Batiha
75 [GO] 2022―Apr―01 Comorbidities and clinical complications associated with SARS-CoV-2 infection: an overview Anamika Gupta, Hezlin Marzook, Firdos Ahmad
76 [GO] 2022―Mrz―29 Cellular and humoral immune response to SARS-CoV-2 mRNA vaccines in patients treated with either Ibrutinib or Rituximab Barbora Bacova, Zuzana Kohutova, Ivana Zubata, Lubica Gaherova, Petr Kucera, Tomas Heizer, et al. (+3)
77 [GO] 2022―Feb―21 A single dose of COVID-19 vaccine induces a strong T cell and B cell response in healthcare professionals recovered from SARS-CoV-2 infection Paula Laranjeira, Tiago Rodrigues, Ana Silva, Pedro Barbosa, Teresa Reis, Cristiana Lopes, et al. (+9)
78 [GO] 2022―Feb―16 Correction to: Evaluation of admission levels of P, E and L selectins as predictors for thrombosis in hospitalized COVID-19 patients Mona M. Watany, Said Abdou, Reham Elkolaly, Nashwa Elgharbawy, Hossam Hodeib
79 [GO] 2022―Jan―25 Increased Gal-3BP plasma levels in hospitalized patients infected with SARS-CoV-2 Valentina Gallo, Ana Reis, André Miranda, Carolina Martins, Cláudia Serre-Miranda, Claudia Nobrega, et al. (+16)
80 [GO] 2022―Jan―22 Potential impact of combined influenza and pneumococcal vaccines on the severity of respiratory illness in COVID-19 infection among type 2 diabetic patients Amr Shaaban Hanafy, Waseem M. Seleem, Hany A. Elkattawy
81 [GO] 2022―Jan―21 Evaluation of admission levels of P, E and L selectins as predictors for thrombosis in hospitalized COVID-19 patients Mona M. Watany, Saied Abdou, Reham Elkolaly, Nashwa Elgharbawy, Hossam Hodeib
82 [GO] 2021―Nov―19 Serum hydroxybutyrate dehydrogenase and COVID-19 severity and mortality: a systematic review and meta-analysis with meta-regression Angelo Zinellu, Panagiotis Paliogiannis, Ciriaco Carru, Arduino A. Mangoni
83 [GO] 2021―Nov―06 High levels of Von Willebrand factor markers in COVID-19: a systematic review and meta-analysis Mehrdad Rostami, Hassan Mansouritorghabeh, Mohammad Parsa-Kondelaji
84 [GO] 2021―Nov―05 Evaluation of antibody response to BNT162b2 mRNA COVID-19 vaccine in patients affected by immune-mediated inflammatory diseases up to 5 months after vaccination Davide Firinu, Andrea Perra, Marcello Campagna, Roberto Littera, Giuseppe Fenu, Federico Meloni, et al. (+13)
85 [GO] 2021―Okt―22 Effectiveness of methylprednisolone therapy in patients with a high-risk common type of COVID-19 pneumonia: a retrospective cohort study Lei Liu, Hang Qu, Jun Jian Li, Yan Wei Yang, Qiu Xi Zeng, Yan Wen Gong, et al. (+5)
86 [GO] 2021―Sep―20 Neither inflammatory bowel disease nor immunosuppressants are associated with an increased risk of severe COVID-19: an observational Dutch cohort study Lennard P. L. Gilissen, Stefan G. H. Heinen, Lotte Rijpma-Jacobs, Erik Schoon, Ramon-Michel Schreuder, Anne-Marie Wensing, et al. (+4)
87 [GO] 2021―Sep―12 FURIN correlated with immune infiltration serves as a potential biomarker in SARS-CoV-2 infection-related lung adenocarcinoma Lianxiang Luo, Manshan Li, Jiating Su, Xinyue Yao, Hui Luo
88 [GO] 2021―Aug―23 COVID-19-associated opportunistic infections: a snapshot on the current reports Amir Abdoli, Shahab Falahi, Azra Kenarkoohi
89 [GO] 2021―Jun―05 Unbiased identification of clinical characteristics predictive of COVID-19 severity Elliot H. Akama-Garren, Jonathan X. Li
90 [GO] 2021―Mai―22 Usefulness of rapid antigen testing for SARS-CoV-2 screening of healthcare workers: a pilot study Anja Šterbenc, Viktorija Tomič, Urška Bidovec Stojković, Katja Vrankar, Aleš Rozman, Mihaela Zidarn
91 [GO] 2021―Apr―25 Kidney disease and COVID-19 disease severity-systematic review and meta-analysis Jagmeet Singh, Preeti Malik, Nidhi Patel, Suveenkrishna Pothuru, Avantika Israni, Raja Chandra Chakinala, et al. (+8)
92 [GO] 2021―Mrz―17 Correction to: Anemia in patients with Covid-19: pathogenesis and clinical significance Gaetano Bergamaschi, Federica Borrelli de Andreis, Nicola Aronico, Marco Vincenzo Lenti, Chiara Barteselli, Stefania Merli, et al. (+15)
93 [GO] 2021―Feb―09 Clinical presentation, therapeutic approach, and outcome of young patients admitted for COVID-19, with respect to the elderly counterpart Martino Pepe, Charbel Maroun-Eid, Rodolfo Romero, Ramón Arroyo-Espliguero, Inmaculada Fernàndez-Rozas, Alvaro Aparisi, et al. (+23)
94 [GO] 2021―Feb―04 Clinical characteristics and potential factors for recurrence of positive SARS-CoV-2 RNA in convalescent patients: a retrospective cohort study Zhi Ao, Yan Li, Jiawei Wei, Jinyue Jiang, Xiaohui Wang, Peng Zhang, et al. (+10)
95 [GO] 2021―Jan―28 Serum albumin concentrations are associated with disease severity and outcomes in coronavirus 19 disease (COVID-19): a systematic review and meta-analysis Panagiotis Paliogiannis, Arduino Aleksander Mangoni, Michela Cangemi, Alessandro Giuseppe Fois, Ciriaco Carru, Angelo Zinellu
96 [GO] 2021―Jan―08 Anemia in patients with Covid-19: pathogenesis and clinical significance Gaetano Bergamaschi, Federica Borrelli de Andreis, Nicola Aronico, Marco Vincenzo Lenti, Chiara Barteselli, Stefania Merli, et al. (+15)
97 [GO] 2021―Jan―08 COVID-19: time to flatten the infodemic curve Anastasios Tentolouris, Ioannis Ntanasis-Stathopoulos, Panayotis K. Vlachakis, Diamantis I. Tsilimigras, Maria Gavriatopoulou, Meletios A. Dimopoulos
98 [GO] 2020―Okt―30 Emerging treatment strategies for COVID-19 infection Maria Gavriatopoulou, Ioannis Ntanasis-Stathopoulos, Eleni Korompoki, Despina Fotiou, Magdalini Migkou, Ioannis-Georgios Tzanninis, et al. (+4)
99 [GO] 2020―Sep―19 Clinical characteristics of moderate and severe cases with COVID-19 in Wuhan, China: a retrospective study Lingshuang Sheng, Xiong Wang, Ning Tang, Fankai Meng, Liang Huang, Dengju Li
100 [GO] 2020―Jul―29 Physical exercise as a tool to help the immune system against COVID-19: an integrative review of the current literature Matheus Pelinski da Silveira, Kimberly Kamila da Silva Fagundes, Matheus Ribeiro Bizuti, Édina Starck, Renata Calciolari Rossi, Débora Tavares de Resende e Silva
101 [GO] 2020―Jul―27 Organ-specific manifestations of COVID-19 infection Maria Gavriatopoulou, Eleni Korompoki, Despina Fotiou, Ioannis Ntanasis-Stathopoulos, Theodora Psaltopoulou, Efstathios Kastritis, et al. (+2)
 [1] 

101 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.005 sec